Abstract
Liver GVHD has declined in recent years but still remains a serious complication of HSCT. The characteristic features involve damaged small bile ducts and cholestasis. There are several different presentations of liver GVHD including those which present as acute GVHD with skin and especially gut involvement. Prolonged acute GVHD of the liver first targets and destroys bile ducts, leading to marked secondary changes of cholestasis. Another presentation of GVHD occurs later as a slowly progressing cholestatic injury without elevations of aminotransferases. Evaluation of liver GVHD involves cytokeratin immunostaining, which helps identify and quantify the bile ducts, and other stains including the periodic acid-Schiff (PAS) stain, which highlights the hepatic architecture and helps identify abnormal and damaged bile ducts. The interpretation of posttransplant liver biopsies must incorporate clinical factors including time posttransplant, exposure to immunosuppression, and other potential causes including drug-induced liver injury (DILI).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lefkowitch JH, Lobritto SJ, Brown RS Jr, et al. Ground-glass, polyglucosan-like hepatocellular inclusions: a “new” diagnostic entity. Gastroenterology. 2006;131(3):713–8.
Wisell J, Boitnott J, Haas M, et al. Glycogen pseudoground glass change in hepatocytes. Am J Surg Pathol. 2006;30(9):1085–90.
Keel SB, Abkowitz JL. The microcytic red cell and the anemia of inflammation. N Engl J Med. 2009;361(19):1904–6.
Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. BiolBlood Marrow Transplant. 2006;12(5):506–10.
Kida A, McDonald GB. Gastrointestinal, hepatobiliary, pancreatic, and iron-related diseases in long-term survivors of allogeneic hematopoietic cell transplantation. Semin Hematol. 2012;49(1):43–58.
McDonald GB, Frieze D. A problem-oriented approach to liver disease in oncology patients. Gut. 2008;57(7):987–1003.
Matsukuma KE, Wei D, Sun K, Ramsamooj R, Chen M. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). J Gastrointest Oncol. 2016;7(Suppl 1):S21–31.
Shulman HM, Cardona DM, Greenson JK, et al. NIH consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 pathology working group report. Biol Blood Marrow Transplant. 2015;21(4):589–603.
Stueck AE, Schiano TD, Fiel MI. Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease. Mod Pathol. 2018;31(3):442–51.
Strasser SI, Sullivan KM, Myerson D, et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood. 1999;93(10):3259–66.
O’Shea AM, Wilson GJ, Ling SC, Minassian BA, Turnbull J, Cutz E. Lafora-like ground-glass inclusions in hepatocytes of pediatric patients: a report of two cases. Pediatr Dev Pathol. 2007;10(5):351–7.
Kleiner DE. Liver histology in the diagnosis and prognosis of drug-induced liver injury. Clinical Liver Disease. 2014;4(1):12–6.
Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB. A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology. 1988;8(3):463–70.
Gooley TA, Rajvanshi P, Schoch HG, McDonald GB. Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation. Hepatology. 2005;41(2):345–52.
Pidala J, Chai X, Kurland BF, et al. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study. Biol Blood Marrow Transplant. 2013;19(5):784–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Loeb, K.R., Woolston, D.W., Shulman, H.M. (2019). The Pathological Spectrum of Hepatic GVHD. In: Yeung, C., Shulman, H. (eds) Pathology of Graft vs. Host Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-42099-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-42099-8_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42098-1
Online ISBN: 978-3-319-42099-8
eBook Packages: MedicineMedicine (R0)